Ian Hermans

Affiliations: 
University of Oxford, Oxford, United Kingdom 
Google:
"Ian Hermans"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Prasit KK, Ferrer-Font L, Burn OK, et al. (2022) Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect. Oncoimmunology. 11: 2081009
Meijlink MA, Chua YC, Chan STS, et al. (2022) 6″-Modifed α-GalCer-peptide conjugate vaccine candidates protect against liver-stage malaria. Rsc Chemical Biology. 3: 551-560
Jarvis EM, Collings S, Authier-Hall A, et al. (2021) Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy. Frontiers in Immunology. 12: 748741
Fu Z, Mowday AM, Smaill JB, et al. (2021) Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy. Cells. 10
Painter GF, Burn OK, Hermans IF. (2021) Using agonists for iNKT cells in cancer therapy. Molecular Immunology. 130: 1-6
Burn OK, Prasit KK, Hermans IF. (2020) Modulating the Tumour Microenvironment by Intratumoural Injection of Pattern Recognition Receptor Agonists. Cancers. 12
Tang JS, Compton BJ, Marshall A, et al. (2020) Mānuka honey-derived methylglyoxal enhances microbial sensing by mucosal-associated invariant T cells. Food & Function
Holz LE, Chua YC, de Menezes MN, et al. (2020) Glycolipid-peptide vaccination induces liver-resident memory CD8 T cells that protect against rodent malaria. Science Immunology. 5
Li Y, Woods K, Parry-Strong A, et al. (2020) Distinct Dysfunctional States of Circulating Innate-Like T Cells in Metabolic Disease. Frontiers in Immunology. 11: 448
George P, Dasyam N, Giunti G, et al. (2020) Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE). Bmj Open. 10: e034629
See more...